ISIS PHARM INC ISIS (NASDAQ)

$ 17.06
19:09
Change: unch (unch%)
Volume: 1,014,313

Avg. Volume: 1133416
P/E Ratio: 200
EPS (Annual): -1.40
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 95,380
Institutional Shareholders: 85.18%
Last: 17.06
Change: unch (unch%)
Prev. Close: 17.06
Open: 17.90
Day's Range: 16.95 - 17.90
52wk Range: 10.91 - 20.15
Market Value: 1,691,960
Beta: 1.73
12-month EPS Change: 0.00%
Total Return Last 12 Months: +33.91%
Total Return Last 3 Years: +94.35%
Total Return Last 5 Years: +142.67%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on ISIS
Alert me Subscribe

Earnings roundup: GEO Group, Isis Pharmaceuticals

Among the earnings stories for Thursday, Aug. 7, from AP Financial News: BOCA RATON, Fla. (AP)--GEO Group Inc., which operates prisons and mental health facilities, on Thursday rep...READ MORE
Aug 07, 2008 3:22PM
Keywords: GEO, ISIS, GPOR, KG, DUF, ARD, SLE

Isis 2Q loss shrinks on collaboration revenue

(CARLSBAD, Calif.)Biotechnology company Isis Pharmaceuticals Inc. said Thursday its second-quarter loss narrowed due to greater revenue from research collaborations. Isis reported a loss of $2.2 mil...READ MORE
Aug 07, 2008 11:04AM
Keywords: ISIS, ALNY, BMY, ABT, GENZ, GSK

Alnylam 2Q loss edges higher on research costs

(CAMBRIDGE, Mass.)Biotechnology company Alnylam Pharmaceuticals Inc. said Thursday its second-quarter loss increased slightly, as rising expenses canceled out improved revenue from collaborations.READ MORE
Aug 07, 2008 7:19AM
Keywords: ALNY, NVS, BIIB, ISIS

Abbott Labs invests $20M in Isis Pharma unit Ibis

(CARLSBAD, Calif.)Isis Pharmaceuticals Inc. said Monday its Ibis Biosciences Inc. unit received an additional $20 million investment from drug and medical device maker Abbott Laboratories.READ MORE
Jul 01, 2008 7:28AM
Keywords: ISIS, ABT

Teva to conduct more research on mid-stage MS drug

(NEW YORK)Teva Pharmaceuticals Industries Ltd., the world's largest generic drug maker, said late Sunday its multiple sclerosis drug met goals of a mid-stage trial, and the company will ...READ MORE
Jun 30, 2008 8:50AM
Keywords: ISIS, TEVA

Genzyme and Isis finalize cholesterol drug deal

(CAMBRIDGE, Mass.)Genzyme Corp. and Isis Pharmaceuticals Inc. said Tuesday they finalized their agreement to give Genzyme exclusive rights to mipomersen, a cholesterol drug candidate discovered and ...READ MORE
Jun 24, 2008 10:03AM
Keywords: GENZ, ISIS

Alnylam shares rise on new Japanese partnership

(NEW YORK)Alnylam Pharmaceuticals Inc. on Thursday signed its second collaborative deal in as many months, sending shares higher. The Cambridge, Mass.-based company will work with Japanese d...READ MORE
Jun 19, 2008 12:10PM
Keywords: ALNY, MRK, RXII, ISIS
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN +30.20 60.88
AMYLIN PHARMA I -55.90 21.48
GILEAD SCIENCES +22.60 49.98
BIOGEN IDEC INC -21.40 48.16
GENENTECH INC +33.70 96.50